View in EDS

Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier.

Saved in:
Bibliographic Details
Title: Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier.
Authors: Puchongmart C; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Rodriguez CC; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Soliman D; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Shotelersuk V; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Sivakumar N; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Yanpiset P; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Thiravetyan B; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Leelaviwat N; Division of Cardiovascular Disease, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX., Sly Z; Division of Cardiovascular Disease, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX.
Source: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2026 Jul 06. Date of Electronic Publication: 2026 Jul 06.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7902492 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4023 (Electronic) Linking ISSN: 01602446 NLM ISO Abbreviation: J Cardiovasc Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1533-4023
DOI:10.1097/FJC.0000000000001855